Remicade (infliximab) : two year results from the ATTRACT study demonstrate sustained benefits in signs and symptoms, structural damage and physical function in patients with rheumatoid arthritis

• HARRIMAN GR.

収録刊行物

• リウマチ

  リウマチ 41 305-, 2001

詳細情報

• CRID: 1573950399403244672
• NII論文ID: 10008132072
• データソース種別:
  • CiNii Articles